Cantor Fitzgerald Maintains Overweight on Upexi, Lowers Price Target to $1.3

Cantor Fitzgerald analyst Gareth Gacetta maintains Upexi (NASDAQ:UPXI) with a Overweight and lowers the price target from $2 to $1.3.